Author

A. Barnett

h-index 0 View on Semantic Scholar

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial

Analysis of secondary outcomes suggests therapeutic promise, but rigorous evaluation in large-scale randomised controlled trials is essential to determine the true efficacy and clinical utility of intravenous remdesivir in people with Long COVID (LC).

M. Faghy, J. Chynoweth, A. Barnett et al. · medRxiv · 0 citations

Open access Jul 2026

Conserved folds enable immune antagonism across the tree of life

The Viral Compendium is established, a database of over 350,000 proteins and domains from eukaryotic, bacterial, and archaeal viruses, to demonstrate that pathogen immune evasion is built upon conserved structural building blocks, revealing unified mechanisms and effectors of immune antagonism spanning all domains of l...

L. Profeta, Erin E. Doherty, Johanna M. Ebner et al. · bioRxiv · 0 citations